GoodRx

NSQ:GDRX · US38246G1085

Health Care TechnologyMedium

360

Value62

Profit price57

EV / EBIT89

Price / Owner Earnings24

Cash yield28

Owner Earnings Yield54

Dividend Yield1

Sales & asset price73

Price/Sales57

EV / Gross Profit95

Price/Book68

Quality67

Returns on capital56

Return on Capital68

Cash Return on Capital54

Return on Equity45

Profit margins73

EBIT Margin74

Gross Profitability72

Cash backing72

Cash Conversion97

Accruals67

Owner Earnings Margin52

Growth18

Sales growth12

Profit growth20

Profit Growth45

Long-Term EPS Growth1

Owner Earnings Growth15

Reinvestment85

Price momentum24

Safety38

Debt load40

Debt serviceability60

Refinancing90

Debt Payback30

Liquidity38

Sentiment49

Analyst ratings21

Expectations trend40

Opinion Changes50

Price Target Upside29

Market mood13

Value Creation8/20creating some value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

GoodRx clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA

IndustryHealth Care Technology

SizeMedium

TypePublic Company

ExchangeNASDAQGS

Founded2015

Websiteinvestors.goodrx.com

ISINUS38246G1085

Last UpdateApr 2, 2026

Indices

NASDAQ (USA)

Themes

Digital Wellness

Description

GoodRx Holdings, Inc. (GoodRx) operates as a consumer-focused digital healthcare platform in the United States. The company expanded platform improves the health and financial well-being of American families by providing easy access to price transpa…

Analysis

Quality compounder

GoodRx Holdings, Inc. earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess.

On valuation, the picture is expensive. The owner-earnings multiple stands at 26.9×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 10% a year, against analyst forecasts of -3%. The market is pricing in far more than analysts expect: heroic expectations.

Growth is weak; the safety picture is stretched. The company scores 8/20 on our value-creation score: creating some value.

Flags to be aware of: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250

2026

All-time high

Jun 2026

All-time low

Mar 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare GoodRx with its peers

Sezzle

NAQ:SEZL

CountryUSA

IndustryDiversified Financial Services

SizeMedium

Full Stock Analysis →

Paysign

NAQ:PAYS

—

CountryUSA

IndustryDiversified Financial Services

SizeSmall

Full Stock Analysis →

OneStream

NSQ:OS

CountryUSA

IndustrySoftware

SizeMedium

Full Stock Analysis →

Navan

NSQ:NAVN

CountryUSA

IndustryHotels, Restaurants & Leisure

SizeMedium

Full Stock Analysis →

IZEA Worldwide

NAQ:IZEA

CountryUSA

IndustryInteractive Media & Services

SizeSmall

Full Stock Analysis →

Draftkings

NSQ:DKNG

CountryUSA

IndustryHotels, Restaurants & Leisure

SizeLarge

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →